With a doctorate in Pharmacy, a PhD in Dermatology and Immunology and an EMBA from INSEAD, Anne de Brugerolle has made a career in the pharmaceutical industry where she has gained in-depth experience of Drug Safety in Dermatology, Immunology and Transplantation and solid knowledge of Business Development at Novartis Pharmaceuticals AG.
Her expertise in these fields of research and her experience in international development will enable her to deploy SkinEthic's sales strategy.
Martin Rosdy, Founder of SkinEthic, will continue to place his knowledge at the service of the L'Oréal group, while at the same time working on new concepts and applications in the field of reconstructed skin. In February 2006, Episkin, a L'Oréal subsidiary, bought the company SkinEthic located in Nice on the tissue engineering market. This rapprochement gave birth to a world leader in this field, at the head of unique know-how in the reconstruction of epidermis, epitheliums or oral, corneal, gingival, esophageal, pulmonary and vaginal mucosa. These models are accompanied by analytical methods used to produce kits of these tissues in order to develop alternative in vitro methods, which are reliable and reproducible.